Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum days for report: 90 days

What are the prerequisites for the test Clinical Exome Sequencing (CES) Test - TRIOS

  • Patients must have a signed consent form from a healthcare provider
  • Patients must provide a detailed medical history
  • Patients must have a valid prescription for the test
  • Patients must have insurance coverage or be willing to pay out of pocket

What are the measure values for the test Clinical Exome Sequencing (CES) Test - TRIOS

  • Test Name: Clinical Exome Sequencing (CES) Test - TRIOS
  • Measure Values:
    • Gene Panels: 20,000+
    • Coding Region: >99.9%
    • Noncoding Region: >98%
    • Clinical Sensitivity: >95%
    • Clinical Specificity: >99%
    • Turnaround Time: 4-6 weeks

What does this test Clinical Exome Sequencing (CES) Test - TRIOS identify?

  • Genetic mutations associated with rare diseases
  • Carrier status for genetic conditions
  • Potential risk for developing certain hereditary conditions
  • Pharmacogenetic information for personalized medicine

Why is this test Clinical Exome Sequencing (CES) Test - TRIOS taken?

Why is the Clinical Exome Sequencing (CES) Test - TRIOS taken?

The Clinical Exome Sequencing (CES) Test - TRIOS is taken to identify the genetic cause of a suspected genetic disorder in an individual. This test is often recommended when other genetic tests have not provided a diagnosis or when there is a strong suspicion of a genetic condition based on the individual's symptoms and medical history.

The CES test analyzes the protein-coding regions of the genome, known as the exome, which are responsible for the majority of genetic disorders. By sequencing these regions, the test can identify genetic variations that may be causing the individual's symptoms.

In some cases, the CES test may be recommended for a trio of individuals, typically the affected individual and their biological parents. This trio testing can help identify de novo mutations, which are genetic changes that occur spontaneously in the affected individual and are not present in either parent.

No FAQs available.

Customer Google Rating